776,651 Shares in HealthEquity, Inc. $HQY Bought by Park West Asset Management LLC

Park West Asset Management LLC purchased a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 776,651 shares of the company’s stock, valued at approximately $70,147,000. HealthEquity accounts for 4.8% of Park West Asset Management LLC’s investment portfolio, making the stock its 3rd biggest position. Park West Asset Management LLC owned approximately 0.93% of HealthEquity as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Oxbow Advisors LLC acquired a new stake in HealthEquity during the 1st quarter worth approximately $3,147,000. Deutsche Bank AG purchased a new position in shares of HealthEquity in the second quarter valued at $11,986,000. Maridea Wealth Management LLC acquired a new stake in HealthEquity during the 2nd quarter valued at $2,753,000. Westfield Capital Management Co. LP increased its stake in HealthEquity by 13.7% during the 4th quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company’s stock worth $178,864,000 after buying an additional 235,794 shares during the period. Finally, Sumitomo Mitsui DS Asset Management Company Ltd acquired a new stake in shares of HealthEquity during the fourth quarter valued at about $4,381,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on HQY shares. Royal Bank Of Canada upped their target price on HealthEquity from $100.00 to $108.00 and gave the company an “outperform” rating in a research report on Wednesday, June 3rd. Wall Street Zen upgraded shares of HealthEquity from a “hold” rating to a “buy” rating in a research note on Saturday, August 22nd. Wells Fargo & Company set a $111.00 price objective on shares of HealthEquity in a report on Monday, June 1st. Barrington Research reissued an “outperform” rating and issued a $110.00 target price on shares of HealthEquity in a research report on Friday, May 22nd. Finally, KeyCorp restated an “overweight” rating on shares of HealthEquity in a research note on Tuesday, May 26th. Eleven investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $110.93.

Insider Buying and Selling

In other news, EVP Michael Henry Fiore sold 3,142 shares of HealthEquity stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the sale, the executive vice president owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. The trade was a 5.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 7,966 shares of company stock valued at $756,770. 1.60% of the stock is currently owned by corporate insiders.

HealthEquity Stock Performance

Shares of NASDAQ HQY opened at $104.42 on Thursday. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. The firm’s 50-day moving average price is $97.77 and its two-hundred day moving average price is $87.71. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $107.62. The stock has a market capitalization of $8.73 billion, a P/E ratio of 39.11, a P/E/G ratio of 1.77 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company had revenue of $354.64 million for the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity’s revenue was up 7.2% compared to the same quarter last year. As a group, sell-side analysts forecast that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.